Japan Launches ‘Safety Net’ Initiative As PMDA Looks To Resolve Drug Lag With The West (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Japan's Pharmaceuticals and Medical Devices Agency has started a new pilot program for risk management, tentatively being called the "product management" initiative. Under the initiative, a group will be created within PMDA's Office of Safety to oversee a new drug throughout its life cycle. Initial plans called for only a handful of drugs being involved. The agency hopes to finish the pilot program within six months, in time for the initiative to be operational some time in the spring
You may also be interested in...
Global Pharmaceutical Outfits, While Closing Discovery Centers In Japan, Are Forging Alliances With Japanese Researchers (Part 3 Of 3)
Several multinational pharmaceutical companies have shut down their Japan-based discovery research facilities over the last few years. Some are relying more on discovery partnerships with local drug research entities in Japan. PharmAsia News' Tokyo bureau examines the factors behind the trend in this third article in a three-part series on the subject. Part one appeared in PharmAsia News on July 13, 2009, and part two appeared on July 20.
Global Pharmaceutical Outfits, While Closing Discovery Centers In Japan, Are Forging Alliances With Japanese Researchers (Part 3 Of 3)
Several multinational pharmaceutical companies have shut down their Japan-based discovery research facilities over the last few years. Some are relying more on discovery partnerships with local drug research entities in Japan. PharmAsia News' Tokyo bureau examines the factors behind the trend in this third article in a three-part series on the subject. Part one appeared in PharmAsia News on July 13, 2009, and part two appeared on July 20.
Japan’s PMDA Adds ‘Safety Net’ Initiative To Resolve Drug Lag: An Interview With PMDA (part 2 of 2)
In part 2 of this series, Kaoru Misawa outlines PMDA’s intentions for the initiative and industry reaction in Japan.